- Home
- UBS vs MDT Comparison
UBS vs MDT Comparison
Compare UBS & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBS
- MDT
- Stock Information
- Founded
- UBS 1862
- MDT 1949
- Country
- UBS Switzerland
- MDT Ireland
- Employees
- UBS N/A
- MDT N/A
- Industry
- UBS Major Banks
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- UBS Finance
- MDT Health Care
- Exchange
- UBS Nasdaq
- MDT Nasdaq
- Market Cap
- UBS 122.4B
- MDT 114.9B
- IPO Year
- UBS N/A
- MDT N/A
- Fundamental
- Price
- UBS $39.75
- MDT $92.25
- Analyst Decision
- UBS Buy
- MDT Buy
- Analyst Count
- UBS 3
- MDT 15
- Target Price
- UBS N/A
- MDT $102.62
- AVG Volume (30 Days)
- UBS 1.8M
- MDT 7.3M
- Earning Date
- UBS 10-29-2025
- MDT 08-19-2025
- Dividend Yield
- UBS 1.87%
- MDT 3.09%
- EPS Growth
- UBS 232.88
- MDT 21.95
- EPS
- UBS 1.89
- MDT 3.62
- Revenue
- UBS $47,011,000,000.00
- MDT $34,200,000,000.00
- Revenue This Year
- UBS $3.08
- MDT $7.58
- Revenue Next Year
- UBS $3.59
- MDT $5.40
- P/E Ratio
- UBS $19.88
- MDT $25.40
- Revenue Growth
- UBS 1.24
- MDT 4.98
- 52 Week Low
- UBS $25.75
- MDT $79.29
- 52 Week High
- UBS $40.71
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- UBS 56.93
- MDT 52.47
- Support Level
- UBS $39.19
- MDT $87.50
- Resistance Level
- UBS $40.71
- MDT $93.83
- Average True Range (ATR)
- UBS 0.41
- MDT 1.56
- MACD
- UBS -0.17
- MDT -0.06
- Stochastic Oscillator
- UBS 36.72
- MDT 68.44
About UBS UBS Group AG Registered
The core of UBS is its global wealth management business focusing on high and ultra-high-net-worth individuals. UBS is also a conventional retail and commercial bank in its Swiss home market. Its investment bank and asset management businesses support its wealth management operations, but also leverage its strength in wealth management to serve third-party clients.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.